Modalis Therapeutics Corporation
Modalis, Inc. Notice of Large Exercise of the 19th Stock Acquisition Rights
Modalis, Inc. conducted a large exercise of the 19th stock acquisition rights from July 7 to 23, 2026, resulting in the issuance of 3,440,000 shares. The number of unexercised stock acquisition rights decreased to 16,210,000 shares.
Key Figures
- Number of Shares Issued: 3,440,000 shares
- Number of Unexercised Stock Acquisition Rights: 162,100 units (16,210,000 shares)
- Total Issuance: 240,000 units
AI要約
Status of Stock Acquisition Rights Exercise
Modalis, Inc. carried out a large exercise of the 19th stock acquisition rights from July 7 to 23, 2026, issuing a total of 3,440,000 shares. The exercise ratio was 14.3%, and unexercised stock acquisition rights decreased to 16,210,000 shares. The exercised shares were mainly concentrated between July 10 and 23, with exercise prices ranging from 33 yen to 34 yen. As a result, there are concerns about dilution of shares outstanding, but it is considered part of fundraising and shareholder return strategies.
Future Outlook and Impact on Shareholders
While the exercise of stock acquisition rights may lead to further share dilution, details about the use of funds and future issuance plans are unknown. Unexercised stock acquisition rights still exist, and their exercise in the future could impact shareholder value. Investors should pay attention to future trends in share issuance and fundraising activities.
Modalis, Inc.
Company overview · Stock price · Financial data · All IR
